tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ZYME Stock Latest News

Zymeworks price target raised to $48 from $33 at Evercore ISI
The FlyZymeworks price target raised to $48 from $33 at Evercore ISI
3d ago
RPRX
ZYME
Zymeworks Earnings Call: Zanidatumab Drives Bullish Outlook
PremiumCompany Announcements
Zymeworks Earnings Call: Zanidatumab Drives Bullish Outlook
4d ago
ZYME
Zymeworks price target raised to $46 from $32 at H.C. Wainwright
PremiumThe Fly
Zymeworks price target raised to $46 from $32 at H.C. Wainwright
6d ago
ZYME
Zymeworks: Strengthened Liquidity and Preserved Zanidatamab Royalty Upside Support Overweight Rating
PremiumRatings
Zymeworks: Strengthened Liquidity and Preserved Zanidatamab Royalty Upside Support Overweight Rating
9d ago
ZYME
Zymeworks price target raised to $47 from $40 at Stifel
PremiumThe Fly
Zymeworks price target raised to $47 from $40 at Stifel
9d ago
ZYME
Zymeworks’ Growth Clouded by High Clinical Failure Risk and Regulatory Uncertainty
PremiumCompany AnnouncementsZymeworks’ Growth Clouded by High Clinical Failure Risk and Regulatory Uncertainty
9d ago
ZYME
Morning Movers: Travel stocks fall following U.S.-Israeli strikes on Iran
Premium
The Fly
Morning Movers: Travel stocks fall following U.S.-Israeli strikes on Iran
10d ago
AAL
COP
Zymeworks Monetizes Ziihera Royalties to Boost Liquidity
Premium
Company Announcements
Zymeworks Monetizes Ziihera Royalties to Boost Liquidity
10d ago
8K
ZYME
Zymeworks Posts Strong 2025 Growth and Bolsters Liquidity
PremiumCompany Announcements
Zymeworks Posts Strong 2025 Growth and Bolsters Liquidity
10d ago
8K
ZYME
Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
PremiumThe Fly
Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
10d ago
ONC
JAZZ
Zymeworks reports Q4 EPS (55c) vs. (31c) last year
PremiumThe Fly
Zymeworks reports Q4 EPS (55c) vs. (31c) last year
10d ago
ZYME
ZYME Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ZYME Upcoming Earnings Report: What to Expect?
12d ago
ZYME
Breakthrough Designation and Expanded Gastroesophageal Opportunity Underpin Buy Rating on Zymeworks and Zanidatamab
PremiumRatingsBreakthrough Designation and Expanded Gastroesophageal Opportunity Underpin Buy Rating on Zymeworks and Zanidatamab
15d ago
ZYME
Zymeworks Sets Date for 2025 Results and Corporate Update
Premium
Company Announcements
Zymeworks Sets Date for 2025 Results and Corporate Update
28d ago
ZYME
Zymeworks to Spotlight Pipeline and Portfolio at Series of Major Healthcare Investor Conferences
Premium
Company Announcements
Zymeworks to Spotlight Pipeline and Portfolio at Series of Major Healthcare Investor Conferences
1M ago
ZYME
Zymeworks Reshapes Board and Executive Team to Support Next Phase of Growth
PremiumCompany Announcements
Zymeworks Reshapes Board and Executive Team to Support Next Phase of Growth
2M ago
ZYME
Zymeworks announces executive changes
PremiumThe Fly
Zymeworks announces executive changes
2M ago
ZYME
Zymeworks outlines priorities, outlook for 2026
PremiumThe Fly
Zymeworks outlines priorities, outlook for 2026
2M ago
ZYME
Zymeworks Sets 2026 Strategy on Zanidatamab Momentum, ADC Pipeline and Cash-Fueled Growth
PremiumCompany Announcements
Zymeworks Sets 2026 Strategy on Zanidatamab Momentum, ADC Pipeline and Cash-Fueled Growth
2M ago
ZYME
Zymeworks (ZYME): Zanidatamab’s Strong Phase 3 HERIZON-GEA Data, Global Milestones, and Royalty Model Support Buy Rating
PremiumRatingsZymeworks (ZYME): Zanidatamab’s Strong Phase 3 HERIZON-GEA Data, Global Milestones, and Royalty Model Support Buy Rating
2M ago
ZYME
Zymeworks’ Ziihera Sets New Survival Benchmark in First-Line HER2-Positive Gastric Cancer Trial
Premium
Company Announcements
Zymeworks’ Ziihera Sets New Survival Benchmark in First-Line HER2-Positive Gastric Cancer Trial
2M ago
ZYME
BeOne Medicines says HERIZON-GEA-01 met dual primary endpoint of PFS
Premium
The Fly
BeOne Medicines says HERIZON-GEA-01 met dual primary endpoint of PFS
2M ago
ONC
JAZZ

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >